Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jorg Dietrich, M.D.,Ph.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Neuroimaging Markers of Treatment-Associated Neurotoxicity in Glioblastoma Patients Undergoing Brain Radiation and Temozolomide Chemotherapy
Summer, 06/11/12 - 08/03/12

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Winter SF, Loebel F, Loeffler J, Batchelor TT, Martinez-Lage M, Vajkoczy P, Dietrich J. Treatment-Induced Brain Tissue Necrosis: A Clinical Challenge in Neuro-Oncology. Neuro Oncol. 2019 Mar 04. PMID: 30828724.
    Citations:    
  2. Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J. Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells. Blood. 2019 May 16; 133(20):2212-2221. PMID: 30808634.
    Citations:    
  3. Nayyar N, White MD, Gill CM, Lastrapes M, Bertalan M, Kaplan A, D'Andrea MR, Bihun I, Kaneb A, Dietrich J, Ferry JA, Martinez-Lage M, Giobbie-Hurder A, Borger DR, Rodriguez FJ, Frosch MP, Batchelor E, Hoang K, Kuter B, Fortin S, Holdhoff M, Cahill DP, Carter S, Brastianos PK, Batchelor TT. MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood Adv. 2019 Feb 12; 3(3):375-383. PMID: 30723112.
    Citations:    
  4. Karschnia P, Sengupta S, Dietrich J. MRI findings in trigeminal neuropathy: bilateral Meckel's cave lesions. Acta Neurol Belg. 2019 Feb 02. PMID: 30712245.
    Citations:    
  5. Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol. 2019 Feb; 20(2):e92-e102. PMID: 30723041.
    Citations:    
  6. Parsons MW, Dietrich J. Assessment and management of cognitive changes in patients with cancer. Cancer. 2019 Jun 15; 125(12):1958-1962. PMID: 30668896.
    Citations:    Fields:    
  7. Gonzalez Castro LN, Dietrich J, Forst DA. Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES). J Cancer Res Clin Oncol. 2018 Dec 11. PMID: 30539279.
    Citations:    Fields:    
  8. Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77. PMID: 30488294.
    Citations:    Fields:    
  9. Ly KI, Oakley DH, Pine AB, Frosch MP, Chiou SH, Betensky RA, Pomerantz SR, Hochberg FH, Batchelor TT, Cahill DP, Dietrich J. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study. Oncologist. 2019 Mar; 24(3):402-413. PMID: 30097523.
    Citations:    Fields:    
  10. Herlopian A, Dietrich J, Abramson JS, Cole AJ, Westover MB. EEG findings in CAR T-cell therapy-related encephalopathy. Neurology. 2018 Jul 31; 91(5):227-229. PMID: 29959264.
    Citations:    Fields:    
  11. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 06 01; 128(6):2651. PMID: 29856368.
    Citations:    Fields:    
  12. Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J Neurosurg. 2018 May 04; 130(3):804-811. PMID: 29726782.
    Citations: 1     Fields:    
  13. Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, Rosen BR, Wen PY, Cahill DP, Batchelor TT. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 2018 04 16; 9(1):1474. PMID: 29662077.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  14. Prust ML, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J. Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss. Neuro Oncol. 2018 01 22; 20(2):289-291. PMID: 29315410.
    Citations:    Fields:    Translation:Humans
  15. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 01 02; 128(1):281-293. PMID: 29202481.
    Citations: 2     Fields:    
  16. Shaw AT, Felip E, Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Lancet Oncol. 2017 12; 18(12):1590-1599. PMID: 29074098.
    Citations: 29     Fields:    Translation:HumansCTClinical Trials
  17. Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT. Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival. NPJ Precis Oncol. 2017; 1. PMID: 29202103.
    Citations:    
  18. Winter SF, Loebel F, Dietrich J. Role of ketogenic metabolic therapy in malignant glioma: A systematic review. Crit Rev Oncol Hematol. 2017 Apr; 112:41-58. PMID: 28325264.
    Citations: 12     Fields:    Translation:HumansAnimals
  19. Roongpiboonsopit D, Kuijf HJ, Charidimou A, Xiong L, Vashkevich A, Martinez-Ramirez S, Shih HA, Gill CM, Viswanathan A, Dietrich J. Evolution of cerebral microbleeds after cranial irradiation in medulloblastoma patients. Neurology. 2017 Feb 21; 88(8):789-796. PMID: 28122904.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  20. Kalpathy-Cramer J, Chandra V, Da X, Ou Y, Emblem KE, Muzikansky A, Cai X, Douw L, Evans JG, Dietrich J, Chi AS, Wen PY, Stufflebeam S, Rosen B, Duda DG, Jain RK, Batchelor TT, Gerstner ER. Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma. J Neurooncol. 2017 02; 131(3):603-610. PMID: 27853960.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  21. Vaios EJ, Nahed BV, Muzikansky A, Fathi AT, Dietrich J. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients. J Neurosurg. 2017 Jul; 127(1):132-138. PMID: 27739940.
    Citations: 4     Fields:    
  22. Dietrich J, Prust M. Author Response. Neurology. 2016 Mar 08; 86(10):979. PMID: 27390802.
    Citations:    Fields:    Translation:Humans
  23. Chamberlain MC. Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology. 2016 Mar 08; 86(10):979. PMID: 26952303.
    Citations:    Fields:    Translation:Humans
  24. LaBuzetta JN, Mordes D, Arrillaga I, Chi A, Dietrich J. A 34-Year-Old Male with An Intracranial Mass. Brain Pathol. 2016 Mar; 26(2):289-90. PMID: 27000488.
    Citations:    Fields:    Translation:Humans
  25. Redjal N, Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, Nahed BV. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol. 2016 May; 127(3):505-14. PMID: 26830093.
    Citations: 5     Fields:    Translation:Humans
  26. Belkind-Gerson J, Hotta R, Whalen M, Nayyar N, Nagy N, Cheng L, Zuckerman A, Goldstein AM, Dietrich J. Engraftment of enteric neural progenitor cells into the injured adult brain. BMC Neurosci. 2016 Jan 25; 17:5. PMID: 26810757.
    Citations:    Fields:    Translation:AnimalsCellsPHPublic Health
  27. Andronesi OC, Loebel F, Bogner W, Marjanska M, Vander Heiden MG, Iafrate AJ, Dietrich J, Batchelor TT, Gerstner ER, Kaelin WG, Chi AS, Rosen BR, Cahill DP. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. Clin Cancer Res. 2016 Apr 01; 22(7):1632-41. PMID: 26534967.
    Citations: 24     Fields:    Translation:Humans
  28. Prust MJ, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J. Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology. 2015 Aug 25; 85(8):683-91. PMID: 26208964.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  29. Redjal N, Agarwalla PK, Dietrich J, Dinevski N, Stemmer-Rachamimov A, Nahed BV, Loeffler JS. Remote acute demyelination after focal proton radiation therapy for optic nerve meningioma. J Clin Neurosci. 2015 Aug; 22(8):1367-9. PMID: 25937571.
    Citations:    
  30. Belkind-Gerson J, Hotta R, Nagy N, Thomas AR, Graham H, Cheng L, Solorzano J, Nguyen D, Kamionek M, Dietrich J, Cherayil BJ, Goldstein AM. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm Bowel Dis. 2015 Apr; 21(4):870-8. PMID: 25742399.
    Citations: 13     Fields:    Translation:AnimalsCells
  31. Etherton MR, Neagu MR, Oakley DH, Koch MJ, Shin JH, Frosch MP, Berkowitz AL, Dietrich J. A 20-year-old man with back pain and lower extremity weakness. JAMA Neurol. 2015 Mar; 72(3):363-6. PMID: 25621865.
    Citations:    Fields:    Translation:Humans
  32. Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. J Neurooncol. 2015 Feb; 121(3):557-63. PMID: 25411098.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  33. Norden AD, Schiff D, Ahluwalia MS, Lesser GJ, Nayak L, Lee EQ, Rinne ML, Muzikansky A, Dietrich J, Purow B, Doherty LM, LaFrankie DC, Pulverenti JR, Rifenburg JA, Ruland SF, Smith KH, Gaffey SC, McCluskey C, Ligon KL, Reardon DA, Wen PY. Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas. J Neurooncol. 2015 Jan; 121(2):297-302. PMID: 25338318.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  34. Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma. Cancer. 2015 Jan 15; 121(2):226-33. PMID: 25204639.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  35. Jordan JT, Plotkin S, Dietrich J. Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 2014 Jul 01; 71(7):918-9. PMID: 24861724.
    Citations: 2     Fields:    Translation:Humans
  36. Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen B, Loeffler JS, Wen PY, Sorensen AG, Jain RK. Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation. Neuro Oncol. 2014 Jul; 16 Suppl 3:iii12. PMID: 25165209.
    Citations:    
  37. Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19059-64. PMID: 24190997.
    Citations: 100     Fields:    Translation:HumansCTClinical Trials
  38. Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro Oncol. 2013 Aug; 15(8):1079-87. PMID: 23828240.
    Citations: 44     Fields:    Translation:HumansCells
  39. Arrillaga-Romany IC, Dietrich J. Imaging findings in cancer therapy-associated neurotoxicity. Semin Neurol. 2012 Sep; 32(4):476-86. PMID: 23361490.
    Citations: 5     Fields:    Translation:HumansAnimals
  40. Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013 Jan; 10(1):14-26. PMID: 23183634.
    Citations: 86     Fields:    Translation:HumansCells
  41. Quant E, Dietrich J, Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology, www.medlink.com. 2010.
  42. Dietrich J, Diamond EL, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Rev Anticancer Ther. 2010 May; 10(5):709-22. PMID: 20470003.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  43. Dietrich J. Chemotherapy associated central nervous system damage. Adv Exp Med Biol. 2010; 678:77-85. PMID: 20738009.
    Citations: 11     Fields:    Translation:HumansCells
  44. Dietrich J. Chemotherapy associated central nervous system damage. Advances in Experimental Biology. 2010; in press.
  45. Dietrich J, Han R, Noble M, Yang M. Tamoxifen impairs neural progenitor cell function . Society for Neuro-Oncology, Annual Meeting, Montreal. 2010.
  46. Dietrich J, Hyrien O, Noble M. Quantitative analysis of the effects of chemotherapy on glial precursor cells. . Cancer Research. 2010; in press.
  47. Yang YM, Han R, Dietrich J, Noble M. CNS progenitor cells and oligodendrocytes are vulnerable to tamoxifen. Cancer Research. 2010; in press.
  48. Dietrich J, Diamond E, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Review Anticancer Therapy. 2010; 10(5):709-722.
  49. Dietrich J. Chemotherapy Associated Central Nervous System Damage. Chemobrain (Robert Raffa, ed). 2010.
  50. Dietrich J, D Wang, T Batchelor. Cediranib (Recentin™) – Profile of a novel anti-angiogenic agent in patients with malignant glioma. Expert Opinion on Investigational Drugs. 2009; 18(10):1-9.
  51. Dietrich J and Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology. 2009; www.medlink.com.
  52. Dietrich J and Proschel C. Role of astrocyte biology in white matter disease. Leukodystrophies (Moser, Naidu, Raymond & Eichler, eds.). 2009.
  53. Dietrich J and Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95.
  54. Dietrich J, Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95. PMID: 19834663.
    Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  55. Dietrich J, Norden AD, Wen PY. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues. Curr Opin Neurol. 2008 Dec; 21(6):736-44. PMID: 19060566.
    Citations: 20     Fields:    Translation:Humans
  56. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008 Dec; 13(12):1285-95. PMID: 19019972.
    Citations: 71     Fields:    Translation:HumansCells
  57. Dietrich J, Monje M, Wefel J, Meyers CM. Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy. The Oncologist. 2008; 13(12):1-13.
  58. Dietrich J, Imitola J, Kesari S. Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas. Nat Clin Pract Oncol. 2008 Jul; 5(7):393-404. PMID: 18521117.
    Citations: 12     Fields:    Translation:HumansCells
  59. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol. 2008; 7(4):12. PMID: 18430259.
    Citations: 66     Fields:    Translation:HumansAnimalsCells
  60. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, and Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the CNS. Journal of Biology. 2008; 7(4):12-24.
  61. Dietrich J, Norden A, Wen PY. Emerging anti-angiogenic treatments for gliomas: Efficacy and safety issues . Current Opinion in Neurology. 2008; 21(6):736-748.
  62. Dietrich J. Late Effects of Treatment for Brain Tumors. Effect of Cancer Treatment on Neural Stem Cells (Christopher Turner and Stewart Goldman - Editors). 2008.
  63. Dietrich J, and P Wen. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (David Schiff, Patrick Wen, and Santosh Kesari - Editors). 2008.
  64. Dietrich J and Wen PY. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (Schiff, Wen, Kesari - Editors). 2008.
  65. Dietrich J, Imitola J., and Kesari S. Mechanisms of Disease: Neural Stem Cells and Gliomas. Nature Clinical Practice Oncology. 2008; 5(7):393-404.
  66. Dietrich J and Wen P. Neurological complications of chemotherapy. MedLink Neurology. 2008; www.medlink.com.
  67. Dietrich J. Effect of Cancer Treatment on Neural Stem Cells. Late Effects of Treatment for Brain Tumors (C Turner and S Goldman - Editors). 2008.
  68. Valaikiene J, Schuierer G, Ziemus B, Dietrich J, Bogdahn U, Schlachetzki F. Transcranial color-coded duplex sonography for detection of distal internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008 Feb; 29(2):347-53. PMID: 18024581.
    Citations: 2     Fields:    Translation:Humans
  69. J Dietrich, Ruolan Han, Miranda Yang, and Mark Noble. Neural Progenitor Cells and Oligodendrocytes Are Highly Sensitive to Chemotherapy. Neurology 68(12). 2007; 68(12):289-290.
  70. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncol. 2006 Sep; 7(9):784. PMID: 16945776.
    Citations:    Fields:    Translation:Humans
  71. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Brain Repair (Mathias Bahr, Editor). 2006; 191-220.
  72. Dietrich J, R Han, Y Yang, M Mayer-Pröschel, and M Noble. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology. 2006; 5(22).
  73. DJ Mock, P Chugh, B Kim, C Pröschel, J Dietrich, F Strathmann, B M Blumberg, and M Mayer-Pröschel. Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors. Retrovirology 3(1). 2006; 3(1):22-23.
  74. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncology. 2006; 7(9):784.
  75. Dietrich J, Kempermann G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol. 2006; 557:191-220. PMID: 16955712.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  76. Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006; 5(7):22. PMID: 17125495.
    Citations: 126     Fields:    Translation:HumansAnimalsCells
  77. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Advances in Exp Medicine and Biology. 2006; 557:191-204.
  78. Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Pröschel M, Noble M, Torres C, Pröschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 Mar; 11(3):277-83. PMID: 15723074.
    Citations: 34     Fields:    Translation:HumansCells
  79. Dietrich J, Noble M and Mayer-Proschel M. Human glial restricted precursor cells - isolation and propagation. 2005.
  80. Noble M and Dietrich J . Brain Tumors (Francis Ali-Osman, Editor). Analysis of neural precursor cells in the context of origin of brain tumors, their treatment, and repair of treatment-associated damage. 2005; 107-124.
  81. Dietrich J, M Lacagnina, D Gass, E Richfield, M Mayer-Pröschel, M Noble, C Torres, and C Pröschel. EIF2B5 mutations compromise generation of GFAP+ astrocytes from neural precursors in Vanishing White Matter leukodystrophy. Nature Medicine. 2005; 11(3):277-283.
  82. Dietrich J and Noble M. Caspase Inhibitors as Anticancer Agents. 2004.
  83. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Pröschel M, Mock DJ. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci. 2004 May 19; 24(20):4875-83. PMID: 15152048.
    Citations: 18     Fields:    Translation:HumansCells
  84. Hau P, Fabel K, Baumgart U, Rümmele P, Grauer O, Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hübner F, Jauch T, Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A, Marienhagen J, Bogdahn U. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer. 2004 Mar 15; 100(6):1199-207. PMID: 15022287.
    Citations: 39     Fields:    Translation:HumansCTClinical Trials
  85. Noble M, Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci. 2004 Mar; 27(3):148-54. PMID: 15036880.
    Citations: 7     Fields:    Translation:HumansAnimals
  86. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, Rao MS, Rothstein JD. Glutamate transporter expression and function in human glial progenitors. Glia. 2004 Jan 15; 45(2):133-43. PMID: 14730707.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  87. Hau P, Fabel K, Baumgart U, Ruemmele P, Grauer O, Bock A, Dietmaier W, Dietrich J et al. Pegylated Liposomal Doxorubicine – Efficacy in Patients with Recurrent High-Grade Glioma. Cancer. 2004; 15(6):1199-1207.
  88. J. Dietrich, B. M. Blumberg, M. Roshal, J. V. Baker, S. D.Hurley, M. Mayer-Pröschel, and D. J. Mock. Human Herpesvirus 6 increases oligodendrocyte differentiation from oligodendrocyte progenitor cells. Journal of Neuro-Virology 10. 2004; 10.
  89. Noble M and Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends in Neuroscience. 2004; 27(3):101-107.
  90. Dietrich J, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock. Infection with an Endemic Human Herpesvirus Disrupts Critical Glial Precursor Cell Properties. Journal of Neuroscience. 2004; 24(20):4875-4883.
  91. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  92. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  93. AH Moore, M Noble, MK O’Banion and J Dietrich. Evaluation of cell proliferation, apoptosis and gliosis following neonatal brain irradiation. Proceedings of the Society for Neuroscience. 2004; 30:940.12.
  94. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock . Infection of human glial precursor cells induces G1/S cell-cycle arrest and alteration of critical cell functions related to activation of DNA damage mechanisms. . Journal of Neurovirology. 2004.
  95. Maragakis NJ, J Dietrich, V Wong, H Xue, M Mayer-Proschel, MS Rao, JD Rothstein. Glutamate transporter expression in human glial progenitors. Glia. 2004; 45(2):133-143.
  96. Dietrich J, Marienhagen J, Schalke B, Bogdahn U, Schlachetzki F. Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. Ann Pharmacother. 2004 Feb; 38(2):242-6. PMID: 14742759.
    Citations: 6     Fields:    Translation:Humans
  97. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A. Salvage therapy in patients with glioblastoma: is there any benefit? Cancer. 2003 Dec 15; 98(12):2678-86. PMID: 14669289.
    Citations: 25     Fields:    Translation:Humans
  98. C Pröschel, J Dietrich, M Lacagninga, D Gass, E Richfield, M Noble, M Mayer-Pröschel. Analysis of glial lineage cells derived from a CACH/VWM leukodystrophy patient. Proceedings of the Society for Neuroscience 29. 2003; 29.
  99. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel, and DJ Mock . Human Herpesvirus 6 Impairs Division and Alters Differentiation of Human Glial Precursors. Journal of Neuro-Virology 9(3). 2003; 9(3):33.
  100. J Dietrich and M Noble. Long-term impairment of cell proliferation and increased cell death in the adult CNS after chemotherapy. Proceedings of the American Association for Cancer Research (AACR). 2003; 44.
  101. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J et al. Salvage Therapy in Patients with Glioblastoma - is there any benefit?. Cancer. 2003; 98(12):2678-2686.
  102. J Dietrich, JV Baker, SD Hurley, B Blumberg, M Mayer-Proschel and DJ Mock . Effects of human herpesvirus type 6 (HHV-6) on cell proliferation and differentiation in human glial precursor cells. Proceedings of the Society for Neuroscience 29. 2003; 29.
  103. Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002 Oct; 40(1):65-77. PMID: 12237844.
    Citations: 33     Fields:    Translation:HumansCells
  104. Dietrich J, Easterday MC. Developing concepts in neural stem cells. Trends Neurosci. 2002 Mar; 25(3):129-31. PMID: 11852138.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  105. Noble M, Dietrich J. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage. Trends Neurosci. 2002 Feb; 25(2):103-7. PMID: 11814563.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  106. Dietrich J, M Noble and M Mayer-Proschel . Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002; 40(1):65-77.
  107. P Hau, J Dietrich, K Fabel, U Baumgart, O Grauer et al. Liposomal doxorubicin with and without tamoxifen in the salvage treatment of high grade glioma – a phase II study. Proceedings of the American Society of Clinical Oncology (ASCO) 38. 2002; 38:312.
  108. Dietrich J and MC Easterday. Developing Concepts in Neural Stem Cells. Trends in Neuroscience. 2002; 25(3):129-131.
  109. P Hau, J Dietrich, K Fabel and U Bogdahn. Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert Reviews in Neurotherapeutics. 2002; 2(5):89-96.
  110. NJ Maragakis, V Wong, H Xue, MS Rao, J Dietrich, M Mayer-Proschel, JD Rothstein. Glutamate transporter expression and function in human glial progenitors. Proceedings of the Society for Neuroscience 28. 2002; 28:424.9.
  111. J Dietrich, M Noble and M Mayer-Proschel. In vitro characterization of human glial restricted precursor cells. Faseb Journal 16(5). 2002; 16(5):1112.
  112. M Noble and J Dietrich. Intersections between neurobiology and oncology: tumor origin, tumor treatment and repair of treatment associated damage. Trends in Neuroscience. 2002; 25(2):103-107.
  113. Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, Steinbrecher A, Ullrich W, Bogdahn U. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer. 2001 Oct 01; 92(7):1936-42. PMID: 11745268.
    Citations: 27     Fields:    Translation:HumansCTClinical Trials
  114. K Fabel, J Dietrich, P Hau et al. Recurrent High-Grade Glioma: Stabilization After Treatment with Pegylated Doxorubicin in Combination with Tamoxifen – a phase II clinical trial. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:2049.
  115. Dietrich J, Hau P, Fabel K, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U . Phase-II Studie bei hochmalignen Gliomen: Stabilisierung unter Therapie mit liposomal verkapseltem Doxorubicin. Aktuelle Neurologie 35. 2001; 35:211.
  116. J Dietrich, Hau P, Fabel K, Zellner A, Steinbrecher A, Ullrich W, and Bogdahn U. Phase II Clinical Trial in High-Grade Glioma: Stabilization of Disease in Patients treated with Liposomal Doxorubicin. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:262.
  117. J Dietrich, DJ Messina, PA Tresco, M Noble, M Mayer-Proschel. Characterization of human glia restricted precursor (hGRP) cells in vitro and after transplantation into the adult mammalian brain. Proceedings of the Society for Neuroscience 27. 2001; 27(2):37.
  118. J Dietrich, M Mayer-Proeschel, M Noble. Chemosensitivity of Glia and Glia Precursor Cells. Proceedings of the American Association for Cancer Research (AACR) 42. 2001; 42:553-554.
  119. Fabel K, Hau P, Dietrich J, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U. 13-cis-Retinsaeure in der Erhaltungstherapie bei makroskopisch tumorfreien Patienten mit hochmalignem Gliom nach Abschluss der Primaertherapie. Aktuelle Neurologie 35. 2001; 35:121.
  120. Aigner L, Fluegel D, Dietrich J, Ploetz S, Winkler J. Isolated lissencephaly sequence and double-cortex syndrome in a German family with a novel doublecortin mutation. Neuropediatrics. 2000 Aug; 31(4):195-8. PMID: 11071144.
    Citations: 4     Fields:    Translation:HumansCells
  121. K Fabel-Schulte, P Hau, J Dietrich, C Wismeth, M Angerer, A Steinbrecher, R Apfel, A Brawanski, U Bogdahn. 13-cis-retinoic acid as a potential treatment in glioma patients who show stable disesase after combined modality treatment. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:662.
  122. J Dietrich, P Hau, K Fabel-Schulte, C Wismeth, M Angerer, A Steinbrecher, W Ulrich, A Brawanski, U Bogdahn. Liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade glioma – a phase I/II study. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:661.
  123. Fabel-Schulte K, Dietrich J, Hau P, Wismeth C, Angerer M, Bogdahn U. Phase I/II pilot study of liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade gliomas. Proceedings of the American Association for Cancer Research (AACR) 41. 2000; 41:1644.
  124. Dietrich J und Bogdahn U. Standard therapy and novel treatment concepts of malignant gliomas. Onkologie. 1999; 3-7.
  125. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M . Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie. 1999; 13(1):2.
  126. P Hau, J Dietrich, U Bogdahn. Therapy of malignant gliomas. Onkologie. 1999; 11:34-35.
  127. Dietrich J, Aigner L, Flügel D, Plötz S, Winkler J. A novel mutation in the doublecortin gene in a family with Doublecortex syndrome and Lissencephaly. Aktuelle Neurologie 26. 1999; 26(1):77-78.
  128. Dietrich J, Sachsenheimer W, Kempermann G, Bach A, Bogdahn U. Decreased expression of VEGF receptor flt-1 in malignant gliomas — semiquantitative analysis of flt-1 mRNA expression in brain tumors using Lamin B as internal standard. Proceedings of the American Association for Cancer Research (AACR) 40. 1999; 40:1512.
  129. C Framme, J Dietrich, CP Lohmann, HG Sachs. Eye involvement in circumscript cutaneous sclerosis - a manifestation of borreliosis?. Klinisches Monatsblatt fur Augenheilkunde. 1999; 215:258-262.
  130. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M. Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie 13. 1999; 13(1):2.
  131. Dietrich J. Expression analysis of the neurotransmitter receptors for dopamine and serotonin, and of the growth factor receptors for Endothelin A, Endothelin B, and VEGF in Human Brain Tumors and Normal Human Brain. 1998.
  132. J Dietrich, G Kempermann, W Sachsenheimer, A Bach, K Fabel-Schulte, U Bogdahn. Expression of endothelin receptors in brain tumors. Journal of Neuro-Oncology 39. 1998; 39(2):269.
  133. F Schlachetzki, T Hoelscher, B Götz, J Dietrich, U Bogdahn. Three dimensional transcranial color-coded duplex sonography - a new perspective?. Aktuelle Neurologie 25. 1998; 25:150.
  134. Dietrich J, Kempermann G, Sachsenheimer W, Bach A, Bogdahn U. Semiquantitative analysis of dopamine receptor expression in human brain tumors. Proceedings of the American Association for Cancer Research (AACR) 39. 1998; 39:2409.
  135. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn. Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders 13. 1998; 13(2):207.
  136. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn . Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders. 1998; 13(2):207.
  137. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology 44. 1998; 44(3):113.
  138. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology. 1998; 44(3):113.
  139. J Dietrich, G Kempermann, HG Kuhn, W Sachsenheimer, A Bach, U Bogdahn. Semiquantitative analysis of VEGF receptor expression in gliomas and normal cortex. Proceedings of the Society for Neuroscience 23. 1997; 23(2445).
  140. Gaiger A, Lion T, Födinger M, Dietrich J, Wolz M, Sillaber C, Henn T, Korninger L, Schwarzinger I, Mitterbauer G, Kyrle P A, Lechner K. Cytogenetic and moleculargenetic analyses in a patient with M-BCR rearranged Philadelphia positive AML. Annals of Hematology 67. 1993; 67:36.
  141. Gaiger A, T Lion, P Kahls, T Henn, J Dietrich, H Greinix, K Feil, K Geissler, K Lechner . Moleculargenetic analyses in patients with chronic myeloid leukemia: Increase of specific mRNA expression during progression to blast crisis. Annals of Hematology 67. 1993; 67:36.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dietrich's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (287)
Explore
_
Co-Authors (83)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.